{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T01:45:38Z","timestamp":1788659138312,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00595-008-3843-2","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T10:21:15Z","timestamp":1231323675000},"page":"27-31","source":"Crossref","is-referenced-by-count":20,"title":["Chemotherapy for small-bowel Adenocarcinoma at a single institution"],"prefix":"10.1007","volume":"39","author":[{"given":"Mitsukuni","family":"Suenaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Mizunuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisho","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuichiro","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Hatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,8]]},"reference":[{"issue":"4","key":"3843_CR1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9610(78)90044-2","volume":"135","author":"G.F. Sager","year":"1978","unstructured":"Sager GF. Primary malignant tumors of the small intestine. A twenty-two year experience with thirty patients. Am J Surg 1978;135(4):601\u2013603.","journal-title":"Am J Surg"},{"issue":"4","key":"3843_CR2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0002-9610(87)90575-7","volume":"153","author":"O. Ciccarelli","year":"1987","unstructured":"Ciccarelli O, Welch JP, Kent GG. Primary malignant tumors of the small bowel. The Hartford Hospital experience, 1969\u20131983. Am J Surg 1987;153(4):350\u2013354.","journal-title":"Am J Surg"},{"key":"3843_CR3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0039-6109(16)43988-5","volume":"664","author":"R.G. Martin","year":"1986","unstructured":"Martin RG. Malignant tumors of the small intestine. Surg Clin North Am 1986;66(4):779\u2013785.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"3843_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","volume":"47","author":"A. Trotti","year":"2000","unstructured":"Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47(1):13\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3843_CR5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E. Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"3843_CR6","first-page":"116","volume":"152","author":"S.W. Ashley","year":"1988","unstructured":"Ashley SW, Wells SA Jr. Tumors of the small intestine. Semin Oncol 1988;15(2):116\u2013128.","journal-title":"Semin Oncol"},{"issue":"3","key":"3843_CR7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9610(80)90176-2","volume":"140","author":"V.K. Mittal","year":"1980","unstructured":"Mittal VK, Bodzin JH. Primary malignant tumors of the small bowel. Am J Surg 1980;140(3):396\u2013399.","journal-title":"Am J Surg"},{"issue":"6","key":"3843_CR8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9610(86)90035-8","volume":"151","author":"R.M. Zollimger Jr","year":"1986","unstructured":"Zollimger RM Jr. Primary neoplasm of the small intestine. Am J Surg 1986;151(6):654\u2013658.","journal-title":"Am J Surg"},{"issue":"4","key":"3843_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02303567","volume":"1","author":"D.B. Frost","year":"1994","unstructured":"Frost DB, Mercado PD, Tyrell JS. Small bowel cancer: a 30-year review. Ann Surg Oncol 1994;1(4):290\u2013295.","journal-title":"Ann Surg Oncol"},{"key":"3843_CR10","first-page":"564","volume":"1375","author":"M.S. Talamonti","year":"2002","unstructured":"Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 2002;137(5):564\u2013570; discussion 570\u20131.","journal-title":"Arch Surg"},{"key":"3843_CR11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.10-2-132","volume":"10","author":"M.K. Gibson","year":"2005","unstructured":"Gibson MK, Holcroft CA, Kvols LK, Haller D. Phase II study of 5-fluorouracil, doxorubicin and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 2005;10:132\u2013137.","journal-title":"Oncologist"},{"issue":"1","key":"3843_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1097-0142(19840101)53:1<23::AID-CNCR2820530106>3.0.CO;2-U","volume":"53","author":"D. Jigyasu","year":"1984","unstructured":"Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 1984;53(1): 23\u201325.","journal-title":"Cancer"},{"key":"3843_CR13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bjc.1998.523","volume":"784","author":"C. Crawley","year":"1998","unstructured":"Crawley C, Ross P, Norman A, Hill A, Cunningham D. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 1998;78(4):508\u2013510.","journal-title":"Br J Cancer"},{"issue":"5","key":"3843_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1179\/joc.2003.15.5.503","volume":"15","author":"A. Polyzos","year":"2003","unstructured":"Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 2003;15(5):503\u2013506.","journal-title":"J Chemother"},{"issue":"4","key":"3843_CR15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000089678","volume":"69","author":"C. Locher","year":"2005","unstructured":"Locher C, Malka D, Boige V, Lebray P, Elias D, Lasser P, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69(4):290\u2013294.","journal-title":"Oncology"},{"issue":"1","key":"3843_CR16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF01366941","volume":"27","author":"H. Onodera","year":"1997","unstructured":"Onodera H, Nishitai R, Shimizu K, Maetani S, Imamura M. Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate\/5-fluorouracil sequential therapy: report of a case. Surg Today. 1997;27(1):60\u201363.","journal-title":"Surg Today"},{"issue":"6","key":"3843_CR17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jjco\/hyh063","volume":"34","author":"T. Yamao","year":"2004","unstructured":"Yamao T, Shimada Y, Shirao K, Ohtsu A, Ikeda N, Hyodo I, et al. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Jpn J Clin Oncol 2004;34(6):316\u2013322.","journal-title":"Jpn J Clin Oncol"},{"key":"3843_CR18","doi-asserted-by":"crossref","unstructured":"Boku N, Yamamoto S, Shirao K, Doi T, Sawaki A, Koizumi W, et al. Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007;25(18S):LBA4513.","DOI":"10.1200\/jco.2007.25.18_suppl.lba4513"},{"issue":"18S","key":"3843_CR19","first-page":"4514","volume":"25","author":"H. Narahara","year":"2007","unstructured":"Narahara H, Koizumi W, Hara T, Takagane A, Akiya T, Takagi M, et al. Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(18S):4514.","journal-title":"Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol"},{"key":"3843_CR20","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A. Gramont de","year":"2000","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938\u20132947.","journal-title":"J Clin Oncol"},{"key":"3843_CR21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","volume":"355","author":"J. Bennouna","year":"2000","unstructured":"Bennouna J, Monnier A, Rivi\u00e8re A, Milleron B, Lemarie E, Trillet-Lenoir V, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041\u20131047.","journal-title":"Lancet"},{"key":"3843_CR22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H. Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335\u20132342.","journal-title":"N Engl J Med"},{"key":"3843_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","volume":"3514","author":"D. Cunningham","year":"2004","unstructured":"Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351(4):337\u2013345.","journal-title":"N Engl J Med"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-008-3843-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-008-3843-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-008-3843-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T12:18:16Z","timestamp":1589458696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-008-3843-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1007\/s00595-008-3843-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}